Cheryl R. Blanchard - 26 Apr 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: President, CEO, Director, Director
Signature: /s/ Cheryl R. Blanchard
Issuer symbol: ANIK
Transactions as of: 26 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 28 Apr 2022, 17:01:35 UTC
Previous filing: 14 Mar 2022
Next filing: 13 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+24,576	+51%	$0.000000	72,826	26 Apr 2022	Direct	F1
holding	ANIK	Common Stock						11,742	26 Apr 2022	Revocable Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	-24,576	-50%	$0.000000	24,575	26 Apr 2022	Common Stock	24,576	$0.000000	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on April 26, 2020. The 24,576 shares resulting from the RSU vest were retained in full as a result of Dr. Blanchard's election to pay cash to cover the applicable taxes resulting from the RSU vest.
F2	Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee.
F3	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning April 26, 2021.